Cyclacel Pharmaceuticals ... (CYCCP)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 5.93 |
Market Cap | 3.47M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -2.047 |
PE Ratio (ttm) | -3.22 |
Forward PE | n/a |
Analyst | n/a |
Ask | 7.27 |
Volume | 430 |
Avg. Volume (20D) | 4,908 |
Open | 6.60 |
Previous Close | 6.50 |
Day's Range | 6.59 - 7.22 |
52-Week Range | 5.20 - 21.47 |
Beta | undefined |
About CYCCP
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-...
Why Price Moved
News

6 months ago · seekingalpha.com
Cyclacel Pharmaceuticals, Inc. (CYCC) Q2 2024 Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC ) Q2 2024 Earnings Call Transcript August 14, 2024 4:30 PM ET Company Participants Grace Kim - IR Spiro Rombotis - President and CEO Brian Schwartz - CMO Pa...

9 months ago · seekingalpha.com
Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC ) Q1 2024 Earnings Call Transcript May 14, 2024 4:30 PM ET Company Participants Grace Kim - IR Spiro Rombotis - President and CEO Brian Schwartz - CMO Paul ...

2 years ago · seekingalpha.com
Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2022 Earnings Call TranscriptCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Irina Koffler - LifeSci Advisors Spiro Rombotis - President & Chief Exec...